Fabien Guillemot will take part in the European Commission’s Joint Research Centre workshop in Brussels “Towards Standards in Biomedicine”
Poietis contributes to shaping the future standards of 3D bioprinting
On October 21, our founder Fabien Guillemot will take part in the European Commission’s Joint Research Centre workshop in Brussels: 🧬 “3D Bioprinting: Towards Standards in Biomedicine”
This event brings together scientists, industry leaders and regulators to tackle a key question for our field:
How can we make 3D bioprinting reliable, reproducible, and ready for clinical translation?
Fabien will share Poietis’ experience and vision on developing robotic bioprinter and skin manufacturing process, how laser-assisted bioprinting and AI-driven process control can help move from innovative prototypes to standardized biofabrication methods.
For Poietis, contributing to these discussions means more than participating in a workshop.
It’s about helping shape the framework that will define tomorrow’s biomanufacturing practices.
We’re proud to be part of this collective effort and look forward to the exchanges in Brussels!
#PoietisBiosystems #Poietis #3DBioprinting #Biofabrication #Biomedicine #RegenerativeMedicine #Innovation #Poieskin
Follow us
Projected use on NGB
The same laser-assisted process runs on the NGB-R® research platform and continues on the GMP-grade NGB-C® for clinical translation. Map this to your own model →
